Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A

Edna Siima Majaliwa1,2, Kandi Catherine Muze2, Joel Ndayongeje3

  • 1Kilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania.

Insights

Low C-peptide levels in Tanzanian youth with type 1 diabetes mellitus (T1DM) correlate with higher rates of diabetic nephropathy and retinopathy. These findings highlight the need for targeted complication prevention strategies in resource-limited settings.

Area of Science:

  • Endocrinology
  • Diabetology
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1DM) complications are linked to C-peptide levels, but this relationship is understudied in resource-limited nations.
  • C-peptide, a marker of endogenous insulin production, may offer insights into T1DM progression and complication risk.

Purpose of the Study:

  • To investigate the association between C-peptide levels and the prevalence of diabetic nephropathy and retinopathy in young T1DM patients in Dar es Salaam, Tanzania.
  • To identify factors contributing to T1DM complications in a resource-limited African setting.

Main Methods:

  • A cross-sectional study was conducted in Dar es Salaam, Tanzania, from 2021-2022.
  • Participants included 281 individuals aged 0-25 years with T1DM.
  • Diabetic nephropathy and retinopathy were assessed, alongside C-peptide levels, HbA1c, age at diagnosis, and diabetes duration.

Main Results:

  • A majority of participants (71.5%) exhibited low C-peptide levels, and 62.3% had poor glycemic control (HbA1c > 10%).
  • The prevalence of retinopathy was 11.7%, and the risk for nephropathy was 41.3%.
  • Low C-peptide levels were associated with higher rates of retinopathy (13.4%) and high-risk nephropathy (41.8%). Age at diagnosis, poor glycemic control, low C-peptide, and diabetes duration were linked to complications.

Conclusions:

  • Low C-peptide levels are significantly associated with increased risk of nephropathy and retinopathy in young T1DM patients in Tanzania.
  • Age at diagnosis, glycemic control, C-peptide status, and diabetes duration are critical factors influencing complication development.
  • Further prospective research is recommended to understand complication onset and develop effective prevention strategies in similar settings.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
623
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
220
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K